Drugmakers raise prices in Pakistan; GSK cashes in big stake in South Africa's Aspen;

> Pakistani drugmakers say they will raise the average price of all of their drugs by 18%, an increase they say the government is permitting in the absence of a national drug pricing policy. Story

> Kenyan drugmakers are warning that a new value-added tax imposed in September that affects their raw materials could force some of them out of business. Story

> Novartis ($NVS) has launched in Japan its once-daily Ultibro Inhalation Capsules for COPD. Report

> GlaxoSmithKline ($GSK) is cashing in about a third of interests in South African drugmaker Aspen Pharmacare at the same time that it is selling the company a large plant in France as part of its deal for Aspen to buy some of GSK's older thrombosis drug brands. Story

And Finally... Indian drugmaker Cipla has paid $15 million for an additional 14.5% stake in drugmaker Quality Chemical Industries, bringing its total stake to just over 50%. Report